| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1176/AJP.144.11.1403 |
| P698 | PubMed publication ID | 3314536 |
| P2093 | author name string | Wehr TA | |
| Goodwin FK | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1403-1411 | |
| P577 | publication date | 1987-11-01 | |
| P1433 | published in | American Journal of Psychiatry | Q1935368 |
| P1476 | title | Can antidepressants cause mania and worsen the course of affective illness? | |
| P478 | volume | 144 |
| Q36074720 | 'Bipolar missed states': the diagnosis and clinical salience of bipolar mixed states |
| Q45263073 | A different depression: clinical distinctions between bipolar and unipolar depression |
| Q35066472 | A display of hypomania in a depressed male in response to fluvoxamine |
| Q47759280 | A re-examination of antidepressant treatment-emergent mania in bipolar disorders: evidence of gender differences |
| Q35680384 | A review of antidepressant-induced hypomania in major depression: suggestions for DSM-V. |
| Q22242607 | Affective instability as rapid cycling: theoretical and clinical implications for borderline personality and bipolar spectrum disorders |
| Q44335284 | Alcohol dependence and mood disorders |
| Q53963989 | An open study of lamotrigine in refractory bipolar depression. |
| Q35592485 | Antidepressant monotherapy for bipolar type II major depression |
| Q34278845 | Antidepressant-induced mania: an overview of current controversies |
| Q57612670 | Antidepressants in bipolar depression |
| Q52937654 | Are antidepressants less effective in the acute treatment of bipolar I compared to unipolar depression? |
| Q37255271 | Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration |
| Q37224904 | Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder. |
| Q57244668 | Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder |
| Q36286401 | Benefits and limitations of antidepressants and traditional mood stabilizers for treatment of bipolar depression |
| Q48478593 | Bipolar Disorder in Neurologic Illness |
| Q37253023 | Bipolar Disorder: an impossible diagnosis |
| Q35664046 | Bipolar II Disorder in a Primary Care Setting: Clinical Vignette |
| Q35017636 | Bipolar depression: management options |
| Q82235766 | Bipolar disorder |
| Q34977053 | Bipolar disorder detection, ascertainment, and treatment: primary care physician knowledge, attitudes, and awareness |
| Q33957680 | Bipolarity from ancient to modern times: conception, birth and rebirth |
| Q42203150 | Bulimia, tricyclic antidepressants, and mania |
| Q22241088 | Circadian rhythm hypotheses of mixed features, antidepressant treatment resistance, and manic switching in bipolar disorder |
| Q60628023 | Clinical features of antidepressant associated manic and hypomanic switches in bipolar disorder |
| Q35446483 | Cognitive Styles in Mood Disorders: Discriminative Ability of Unipolar and Bipolar Cognitive Profiles |
| Q69377160 | Cognitive impairment, clinical course and treatment history in out-patients with bipolar affective disorder: relationship to tardive dyskinesia |
| Q40866452 | Continuation and maintenance pharmacotherapy for unipolar and bipolar mood disorders. |
| Q38025035 | Continuation and maintenance therapy with antidepressive agents. An overview of research |
| Q34521351 | Current research on rapid cycling bipolar disorder and its treatment |
| Q57703141 | Depressive Disorders: Major Depressive Disorder and Persistent Depressive Disorder |
| Q41459287 | Depressive illness and the possibilities of somatic antidepressant treatment |
| Q50978693 | Dimensional psychopathology of depression: detection of an 'activation' dimension in unipolar depressed outpatients. |
| Q48478796 | Disruption of the activity-rest cycle by MAOI treatment: dependence on light and a secondary visual pathway to the circadian pacemaker |
| Q46078764 | Distinguishing bipolar from unipolar depression: the importance of clinical symptoms and illness features |
| Q42671085 | Do patients with borderline personality disorder belong to the bipolar spectrum? |
| Q43725413 | Dose-response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders |
| Q37475343 | Dothiepin-induced transient hypomania and extrapyramidal syndrome |
| Q34311883 | Drug-induced mania |
| Q34728554 | Drug-induced mania in the elderly |
| Q38627219 | Drug-induced mania--causative agents, clinical characteristics and management. A retrospective analysis of the literature |
| Q37194212 | Duloxetine-induced hypomania: case report and brief review of the literature on SNRIs-induced mood switching |
| Q36732869 | Efficacy and mood conversion rate during long-term fluoxetine v. lithium monotherapy in rapid- and non-rapid-cycling bipolar II disorder |
| Q34185305 | Emerging trends in the treatment of rapid cycling bipolar disorder: a selected review |
| Q34530127 | Ewald Hecker's description of cyclothymia as a cyclical mood disorder: its relevance to the modern concept of bipolar II. |
| Q73308911 | First International Exchange on Bipolar Disorder |
| Q35561522 | Gender differences in bipolar disorder |
| Q51891488 | Gender differences in major depressive disorder and bipolar disorder. |
| Q47582630 | Generalizability of Clinical Trial Results for Adolescent Major Depressive Disorder |
| Q44973734 | Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder |
| Q36187233 | Geriatric Delusional Depression |
| Q42278761 | Hypomania precipitated by psychostimulant use in depressed medically ill patients |
| Q54161652 | Induction of a mixed depressive episode during rTMS treatment in a patient with refractory major depression. |
| Q74283261 | Induction of mania and cycle acceleration in bipolar disorder: effect of different classes of antidepressant |
| Q43751897 | Influence of 5-HTTLPR and TPH variants on illness time course in mood disorders |
| Q25256727 | Influence of postpartum onset on the course of mood disorders |
| Q34503731 | Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? |
| Q48288125 | Kindling and second messengers: an approach to the neurobiology of recurrence in bipolar disorder |
| Q45070775 | Lamotrigine therapy in treatment-resistant menstrually-related rapid cycling bipolar disorder: a case report |
| Q44375860 | Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy |
| Q40758968 | Lithium maintenance therapy for bipolar I patients: possible refractoriness to reinstitution after discontinuation |
| Q41177967 | Long term treatment of bipolar disorder |
| Q34340590 | Long-term naturalistic treatment of depressive symptoms in bipolar illness with divalproex vs. lithium in the setting of minimal antidepressant use. |
| Q27012673 | Management of bipolar I depression: clinical utility of lurasidone |
| Q54997100 | Mania and recovery from chronic fatigue syndrome. |
| Q28142040 | Mania associated with St. John's wort |
| Q37643765 | Mania associated with antidepressant treatment: comprehensive meta-analytic review |
| Q51083721 | Methodological considerations for the development of new treatments for bipolar disorder. |
| Q73239126 | Mood Disorders in Neurologic Illness |
| Q49014491 | Neuroleptic-induced supersensitivity psychosis in patients with bipolar affective disorder |
| Q37810013 | New applications of lithium therapy |
| Q74242303 | On defining 'mood stabilizer' |
| Q73123019 | On the nature of depressive and anxious states in a family practice setting: the high prevalence of bipolar II and related disorders in a cohort followed longitudinally |
| Q38096445 | One-year outcomes of unipolar depression patients with manic or hypomanic switch during acute antidepressant treatment |
| Q51888315 | Overcoming the current approach in bipolar disorder research: towards DSM-V and beyond. |
| Q34726454 | Personalized medicine in psychiatry: problems and promises |
| Q37696244 | Pharmacologic mood destabilization: case vignettes. |
| Q34106689 | Pharmacotherapy of depression and mixed states in bipolar disorder. |
| Q44266758 | Placebo-controlled trials do not find association of olanzapine with exacerbation of bipolar mania |
| Q35947312 | Posttraumatic stress disorder in patients with bipolar disorder: a review of prevalence, correlates, and treatment strategies |
| Q33740408 | Practical Clues to Early Recognition of Bipolar Disorder: A Primary Care Approach |
| Q43849302 | Predictors of antidepressant treatment outcome in melancholia: psychosocial, clinical and biological indicators |
| Q34573426 | Prevalence of Bipolar Disorder symptoms in Primary Care (ProBiD-PC): A Canadian study |
| Q34188366 | Psychotherapy for bipolar depression: a phase-specific treatment strategy? |
| Q44125659 | Psychotic mania in bipolar II depression related to sertraline discontinuation |
| Q33714517 | Psychotropic medication exposure and age at onset of bipolar disorder in offspring of parents with bipolar disorder |
| Q77993014 | Rapid cycling affective disorder: a descriptive study from North India |
| Q35947336 | Rapid cycling bipolar disorder: historical overview and focus on emerging treatments |
| Q50931637 | Rapid-cycling affective disorder in the elderly: clinical subtype or specific course of manic-depressive illness? |
| Q48744831 | Rate of switch from depression into mania after therapeutic sleep deprivation in bipolar depression |
| Q43931805 | Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers |
| Q34106678 | Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders |
| Q51032825 | Refining the evaluation of bipolar II: beyond the strict SCID-CV guidelines for hypomania. |
| Q50997203 | Relevance of anger and irritability in outpatients with major depressive disorder. |
| Q28245269 | Risk of suicidal behavior with antidepressants in bipolar and unipolar disorders |
| Q35645906 | Safety and tolerability of lamotrigine for bipolar disorder |
| Q44783521 | Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rate |
| Q33920217 | Signaling: cellular insights into the pathophysiology of bipolar disorder |
| Q39643090 | Suicide: a guide to risk factors, assessment, and treatment of suicidal patients. |
| Q31951593 | Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP). |
| Q28076486 | The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines |
| Q35041599 | The Maudsley bipolar disorder project. A survey of psychotropic prescribing patterns in bipolar I disorder |
| Q34616633 | The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression |
| Q38219305 | The bipolar diathesis of treatment-resistant major depressive disorder |
| Q51888317 | The broad clinical spectrum of bipolar disorder: implications for research and practice. |
| Q51789654 | The clinical history and costs associated with delayed diagnosis of bipolar disorder. |
| Q69829394 | The dexamethasone suppression test and depression. Approaches to the use of a laboratory test in psychiatry |
| Q33768203 | The evolving bipolar spectrum. Prototypes I, II, III, and IV. |
| Q30355790 | The fallacy of the medical model and the dangers of psychotropic drugs as a mode of treatment for mental disorders. |
| Q34108227 | The role of G proteins in the psychobiology and treatment of affective disorders and their integration with the neurotransmitter hypothesis |
| Q33768249 | The role of bipolarity in depression in the family practice setting |
| Q33962900 | The soft bipolar spectrum redefined: focus on the cyclothymic, anxious-sensitive, impulse-dyscontrol, and binge-eating connection in bipolar II and related conditions |
| Q38610748 | The use of antidepressants in bipolar disorder patients with depression |
| Q48938571 | Transcranial magnetic stimulation-induced switch into mania: a report of two cases |
| Q34661431 | Transition to mania during treatment of bipolar depression |
| Q51939601 | Treatment emergent affective switch: a controlled study. |
| Q40954013 | Treatment of acute bipolar depression: a review of the literature |
| Q40866426 | Treatment of acute mania. |
| Q52278359 | Treatment of bipolar depressive mood disorders: Algorithms for pharmacotherapy. |
| Q34747514 | Treatment of rapidly cycling bipolar patient by using extended bed rest and darkness to stabilize the timing and duration of sleep. |
| Q38219318 | Treatment response and duration of maintenance treatment with adjunctive antidepressants in bipolar depression: A retrospective chart review |
| Q34609823 | Treatment-emergent mania/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder |
| Q41127918 | Treatment-resistant bipolar depression |
| Q44266751 | Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II). |
| Q73897688 | Venlafaxine monotherapy in women with bipolar II and unipolar major depression |
| Q35073803 | What is to be done? Controversies in the diagnosis and treatment of manic-depressive illness |
| Q35182108 | Which antidepressants flick the switch? |
| Q35024109 | World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression |
| Q33782621 | Ziskind-Somerfeld Research Award. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness |
| Q74256423 | [Functional neuroimaging in patients with rapid cycling bipolar depression] |
| Q53855360 | [Manic episodes during antidepressant treatment in bipolar disorder]. |
| Q57698064 | Évolution du trouble bipolaire |
Search more.